Sodium taurodeoxycholate hydrate 是一种胆汁酸，是由肝脏中的胆固醇合成的两亲性表面活性剂分子。 除 TGR5 通路外，Sodium taurodeoxycholate hydrate 还激活 S1PR2 通路。

Sodium taurodeoxycholate hydrate, a bile acid, is an amphiphilic surfactant molecule synthesized from cholesterol in the liver. Sodium taurodeoxycholate hydrate activates the S1PR2 pathway in addition to the TGR5 pathway.

Solid

Microbial Metabolite

The median plasma concentration of Taurodeoxycholate is 33.9 nM in healthy individuals.
Taurodeoxycholate inhibits the binding of N-H-methylscopolamine to the M3 muscarinic receptor of acetylcholine with an IC50 of 170 μM.
Taurodeoxycholate (0.05-1.00 mM; 1-6 days) stimulates intestinal epithelial cell proliferation.
Taurodeoxycholate (0.05-1.00 mM; 24 h) induces a significant increase in S-phase concentration and a significant decrease in G1-phase concentration of the cell cycle, increases c-myc protein and mRNA expression in IEC-6 cells.
has not independently confirmed the accuracy of these methods. They are for reference only.

Taurodeoxycholate (0.5 mg/kg; i.v.; once) confers protection to C57BL/6N mice with sepsis, but does not protect TGR5 KO mice under sepsis. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:

Room temperature in continental US; may vary elsewhere.

Powder -20°C 3 years；4°C 2 years

[1]. Chang S, et al. Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice. Front Immunol. 2018 Sep 18;9:1984.
[2]. Yamaguchi J, et al. Taurodeoxycholate increases intestinal epithelial cell proliferation through c-myc expression. Surgery. 2004 Feb;135(2):215-21.